WHITEHAWK THERAPEUTICS, INC. Cash and Cash Equivalents
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Cash and Cash Equivalents of $85.23 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $85.23M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $34.79M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $37.57M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $37.93M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $85.23M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $34.79M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $37.57M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $37.93M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $144.94M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $227.57M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $28.67M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $30.54M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $41.14M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $53.78M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $62.89M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $68.80M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $68.16M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $34.05M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $39.02M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $134.81M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $118.74M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $129.85M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $148.99M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $161.38M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $36.82M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $39.01M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $4.46M 10-K · filed 2022-03-17 | $42.60M 10-K · filed 2021-03-11 |
| 2020-09-30 | $47.28M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $44.86M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $34.58M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $38.52M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $43.39M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $48.16M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $53.42M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $62.61M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $68.81M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $68.78M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $13.76M 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $20.26M 10-Q · filed 2019-08-08 | |
| 2017-09-30 | $24.83M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $28.85M 10-Q · filed 2018-08-14 | |
| 2017-03-31 | $35.14M 10-Q · filed 2018-05-15 | |
| 2016-12-31 | $1.61M 10-K · filed 2019-03-07 | $4.01K 10-K · filed 2017-03-07 |
| 2016-09-30 | $1.31M 10-Q · filed 2017-11-13 | $7.84K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.60M 10-Q · filed 2017-08-10 | $20.28K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $1.16M 10-Q · filed 2017-05-15 | $13.23K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $5.14M 10-K · filed 2018-03-15 | $18.53K 10-K · filed 2016-03-30 |
| 2015-09-30 | $6.27K 10-K · filed 2017-03-07 | |
| 2015-06-30 | $10.10K 10-Q · filed 2016-08-15 | |
| 2015-03-31 | $23.29K 10-Q · filed 2016-05-16 | |
| 2014-12-31 | $5.26K 10-K · filed 2017-03-07 | |
| 2014-09-30 | $17.87K 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $4.57K 10-Q · filed 2015-08-13 | |
| 2014-03-31 | $5.88K 10-Q · filed 2015-05-13 | |
| 2013-12-31 | $6.28K 10-K · filed 2017-03-07 | |
| 2013-09-30 | $10.29K 10-Q · filed 2014-11-14 | |
| 2013-06-30 | $2.71K 10-Q · filed 2014-11-14 | $18.42K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $2.71K 10-Q · filed 2014-08-14 | |
| 2012-12-31 | $4.61K 10-K · filed 2016-03-30 | |
| 2012-09-30 | $5.39K 10-K · filed 2016-03-30 | |
| 2012-06-30 | $9.31K 10-Q · filed 2013-08-14 | |
| 2012-03-31 | $23.60K 10-Q · filed 2013-05-15 | |
| 2011-12-31 | $4.13K 10-K · filed 2016-03-30 | |
| 2011-09-30 | $6.13K 10-K · filed 2013-03-28 | |
| 2011-06-30 | $9.23K 10-Q · filed 2012-08-14 | |
| 2011-03-31 | $24.63K 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $26.90K 10-K · filed 2013-03-28 | |
| 2010-09-30 | $2.25K 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $5.76K 10-Q · filed 2011-08-15 | |
| 2009-12-31 | $11.14K 10-K · filed 2012-03-30 | |
| 2007-11-16 | $0.00 10-K · filed 2012-03-30 | |
| 2007-11-15 | $0.00 10-Q · filed 2013-05-15 | |
| 2007-11-14 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |